Table 3.
Matters relating to conservative treatment
| Total | Pregnancy | Non-pregnancy | P* | |
|---|---|---|---|---|
| Age of pregnancy permission | 35.0 ± 4.7 | 33.9 ± 4.4 | 36.0 ± 4.8 | 0.023 |
| Number of D&C (times) | 4.98 ± 3.27 | 4.18 ± 2.34 | 5.66 ± 3.77 | 0.049 |
| Endometrial thickness during ovulation (mm) | 7.50 ± 2.08 | 8.56 ± 1.87 | 6.70 ± 1.87 | <0.001 |
| Duration of MPA administration (days) | 357.7 ± 285.4 | 277.5 ± 167.0 | 431.5 ± 342.5 | 0.010 |
| Periods of disappearance of lesions (days) | 164.0 ± 143.1 | 136.2 ± 133.8 | 187.0 ± 147.7 | 0.042 |
| Periods from the last MPA administration to menstruation or starting date of the pregnancy (days) | 314.0 ± 392.8 | ー | ー | |
| Infertile period after conservative treatment (days) | 1146 ± 1024 | 1206 ± 887 | 1096 ± 1131 | 0.116 |
| Follow up (days) | 2032 ± 1266 | 2027 ± 1115 | 2037 ± 1389 | 0.592 |
| Recurrence (%) | 61 (62.2) | 23 (51.1) | 38 (71.7) | 0.036 |
| Intrauterine adhesion (%) | 20/81 (24.7) | 5/29 (17.2) | 15/52 (28.8) | 0.191 |
Note : Values listed as mean ± standard deviation
*Pregnancy versus Non-pregnancy (Mann–Whitney U test)